Since the molecular basis of the selective recognition of a small subpopulation of HLA-B27 molecules by the monoclonal antibody MARB4 is poorly understood, a characterization of the epitope was undertaken. In addition, we analyzed the reactivity of MARB4 with lymphoid cells from transgenic rats.
HLA analysis of the family of a renal transplant patient revealed an extremely rare condition. Ten family members in two generations were investigated. On repeated typings, no HLA-A antigen could be demonstrated on one haplotype of the propositus and his sister.
Serologic typing of HLA-A was performed by CDC with 76 different antisera enabling the detection of all hitherto known serological HLA-A types. The patient was typed A24 and his sister A2. Since they had one haplotype in common, the HLA-A allele of the other haplotype was supposed to be a nullallele. For confirmation, molecular typing methods were used. The PCR-SSP method was performed using five different commercial kits, with which all known HLA-A alleles could be detected. However, with this typing only an A*24 and A*02 allele were detected in patient and sister, respectively. Sequence-based typing (SBT) was performed by separate amplification and sequencing of exons 1, 2, 3 and 4 using 10 different primer combinations. In both individuals again only one allele was identified. These results suggested a deletion of the complete HLA-A gene or a major part of it. To confirm the deletion, microsatellite analysis of the HLA-A locus region was performed with the markers, C3_2_11, D6S265, D6S1260 and D6S276. All 4 microsatellite markers were present and confirmation of HLA-A deletion was not yet possible.
In further investigations the number of primers used for amplification and sequencing of HLA-A will be extended. Furthermore, the region around HLA-A will be narrowed down for microsatellite analysis to definitely demonstrate a deletion of the HLA-A locus.
THE NOVEL SEROLOGICALLY UNDETECTABLE VARIANT HLA-B*35SRE IS CHARACTERIZED BY A DISRUPTED DISULFIDE BOND
Holger-A. Elsner, Constanze Schoenemann, Rainer Blasczyk.
Department of Transfusion Medicine, Hannover Medical School, Hannover, Germany.
The identification of expression variants is a challenge in HLA diagnostics. We here describe the identification of the novel blank allele HLA-B*35SRE which was detected in a cadaveric organ donor. The serological HLA class I type, determined by a lymphocytotoxicity test was A11,24; B38; Bw4; Cw-; whereas the molecular genetic type as identified by PCR-SSP, was A*11,*24, B*35,*38; Bw4 , Bw6; Cw*12, thus indicating the presence of a non-expressed B*35 allele. To clarify the lack of serological HLA-B35 reactivity, exons 2 and 3 were sequenced following haplotype-specific amplification. At position 564 from the beginning of the coding region (exon 3), a transversion (C→G) was observed, which at the amino acid level results in a substitution from cysteine to tryptophane at position 164 of the mature polypeptide. Since this position is essential for the formation of a disulfide bond linking the cysteine residues at positions 101 and 164, which is strongly conserved in functional class I molecules of vertebrates, the disruption of this bond is very likely to be the reason for the lack of serological detectability. As translation into a polypeptide would result in a complete though non-functional B35 molecule, peptides derived from it might be presented via the indirect allorecognition pathway, and thus impair the outcome of hematopoietic stem cell transplantation.
HLA-G GENE EXPRESSION IN HUMAN BLOOD CELLS CULTURED IN VITRO
Enrica Capelli, Rita Vaccarone*, Elena Ansaldo, Marilena Taliani, Nicoletta Carlo-Stella, Laura Salvaneschi˚, M.Cuccia.
Dip. Genetica e Microbiologia, *Dip. Biologia Animale, Università di Pavia, IRCCS Policlinico S.Matteo, Pavia-Italy.
The expression of HLA-G in human blood cells unstimulated and stimulated with different treatment conditions in vitro was studied. The aim was to obtain new information about this non classical HLA receptor in relation with cell subset and differentiation.
HLA-G is a molecule expressed on a part of trophoblast cells, at the interface between mother and foetus, and since its discovery, has been greeted with great interest among immunologists for a possible central role in the immunology of pregnancy. To date seven isoforms derived by alternative mRNA splicing have been described but the biological effect of the derived proteins is still far for being clarified. The hypothesis that a major role of HLA-G is to prevent attack of the placenta by maternal natural killer cells and to avoid immune attack against tumour cells is now object of renewed scrutiny.
In the present study we searched the presence of HLA-G mRNA in blood cells both freshly isolated and after stimulation (PHA, G-CSF, GM-CSF, IL-4) using molecular analysis and immunecytochemistry. Total RNA was obtained by guanidinium thiocyanate method, then mRNA was reverse trancribed and molecular analysis was performed using the RT-PCR method and the following specific primers: G 257 F that recognises a sequence inside exon 2 and G 1225 that recognises a sequence inside 3'UTR region. The immunecytochemical study was performed using MEM-G/1 monoclonal antibody and PAP method.
The results indicate that HLA-G is expressed in normal monocytes and is induced in lymphocytes following activation. Class I molecules encoded by the major histocompatibility complex present endogenous peptide antigens to the immune system and are primarily involved in triggering T cell mediated immune responses. T lymphocyte responses to class I HLA play a critical role in (1) determining the outcome of solid organ and bone marrow transplantation, (2) mediating the elimination of virus and cancerous cells, and (3) the onset of autoimmune responses. A number of functional assays incorporate MHC class I molecules in order to characterize immune responses to these molecules. As the human MHC (HLA) class I molecules are polymorphic and diverse, functional manipulation and characterization of MHC class I mediated immune responses can be markedly enhanced through the use of individual class I proteins in particular experimental assays. Individual class I molecules might therefore be used to diagnose, provide treatment for, and study adaptive immune responses. Soluble HLA antigens represent a possible means of obtaining individual HLA molecules since, except that they lack the transmembrane anchor and the cytoplasmic tail, their structure is that of native HLA antigens in the membrane.
Over the last several years we have initiated the production of truncated recombinant soluble HLA molecules in a hollow fiber bioreactor system and obtained milligram quantities after affinity purification. Currently, 54 specificities of HLA-A, HLA-B and HLA-C molecules are available for a variety of applications. Here, we discuss the HLA toolkit that we have established with these sHLA molecules. A ligand database, a peptide screening assay, and an epitope discovery process have been established with these sHLA molecules. Finally, we propose to utilize this HLA toolkit to better understand vaccine development, autoimmunity, and transplantation. HLA-B27 is an important marker in ankylosing spondylitis. In this study, we have quantitated the binding of molecular equivalents of soluble fluorochrome (MESF) in 257 HLA-B27 positive individuals by flow cytometry (FCM) using the FITC-conjugated mAb FD705 (Medac, Hamburg, Germany). All samples were typed for HLA-B by standard lymphocytotoxicity; the B*27 allelic type was determined by sequencing. 251 individuals were heterozygous (second allele of non-B*27 type), whereas three individuals possessed a B*27 subtype heterozygosity (B*2702,*270502/270504/2713) and three were homozygous for B*270502/270504/2713. In the FCM analysis, for lymphocytes a bimodal normal distribution of MESF was observed, in which 31 individuals (12%), had about three times lower MESF values than the remaining individuals. Of these 31 samples with low MESF values, 29 (94%) were identified as B*2702, one as B*270502/270504/2713, and one as B*2710. Of the 226 remaining samples with high MESF values, 222 were identified as B*270502/270504/2713 (including the three samples with B*27 heterozygosity), and one was identified as B*270503, B*2707, B*2709, and B*2716 each. Accordingly, the quantitation of MESF by FCM reveals previously unknown differences in the serological reactivity of B*27 allelic variants. This method thus proves to be highly sensitive and specific for the differentiation between B*2702 and B*2705 which might be based on different levels of expression rather than different antibody binding kinetics. We have established an online MHC database providing HLA class I and II ligand and motif data to scientists and clinicians. The database has been populated with ligand data from peer-reviewed journals and is available on the World Wide Web at http://hlaligand.ouhsc.edu/. HLA peptide ligands are the target for many immune responses, and algorithms based upon these ligand datasets allow the identification of new peptides for vaccine development and studies of transplantation and autoimmunity. Here, we review the HLA class I dataset to discern the strengths and deficiencies of the database. We presently have over 2000 HLA class I ligands in out database, and these ligands are not distributed evenly between, or within, the HLA-A, -B, and -C l oci. While the -A and -B loci both have over 1000 ligands represented in the database, the HLA-C locus has approximately 100. At the -A locus, 223 phenotypes exist; of these only 23 phenotypes have motifs that have been identified, and 43 have peptides characterized. In terms of number of ligands, HLA-A*0201 has 258 characterized ligands, A*1101 has 25 peptides, while the remaining 2/3 of the HLA-A phenotypes have less than 10 associated peptide sequences. Similar patterns are seen in the HLA-B and -C loci. These data indicate that while a substantial percentage of the current HLA class I phenotypes are represented by ligands in the database, many phenotypes have only a few ligands from which to base predictions. Using this dataset and known allelic frequencies, it is feasible to design future methods for systematically populating the HLA ligand database to maximize epitope identification in the human population. The standard assay for the clinical detection of contact allergy against nickel, the patch test, includes the potential of sensitization, whereas the LTT, an in vitro assay mostly applied for research purposes, demands six days cell culture and radioactive labeling procedures. It was the purpose of this study to validate an ELISpot assay to specifically detect cellular response against nickel sulfate in correlation with patch test, LTT results, and anamnestic data. In probands with positive (N=60) and negative patch test results (N=19) cytokine ELISpot and LTT were performed in parallel using various concentrations of nickel sulfate, numbers of responding PBMC, and cell culture duration. Concentrations of 50 and 75 µM nickel sulfate were found optimal to stimulate in the ELISpot 4x105 and in the LTT 2x105 PBMC, respectively. An increase in ELISpot sensitivity was reached by preincubation with nickel sulfate for 24 h prior to transfer to ELISpot plates. In nickel-sensitive probands, an average precursor cell frequency of 19:105, 1.7:105, and 0.7:105 could be defined for IFN-γ, IL-2, and IL-4 producing PBMC, respectively. In non-sensitive probands IFN-γ producing cells were detectable, but with significantly lower frequency (2:105; P=0.004). The prior performance of patch tests had no significant effect on cytokine production or lymphocyte proliferation. Overall, the parameters patch test, ELISpot, LTT results, and anamnestic nickel allergy were positively correlated (P<0.05).
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Poster Group 3 -Antigenpresentation
Based on these experiments, the quantitative in vitro detection of cell mediated allergic reactions towards nickel as well as other heavy metal ions should be possible utilizing the above described ELISpot assay.
EVALUATION OF CD1D EXPRESSION ON ANTIGEN PRESENTING CELLS IN HUMAN CORD BLOOD
Palasingam Rajananthanan, Anthony Poles, Jesus Gomez, Rena Singh and Cristina V. Navarrete
Research Laboratory, Histocompatibility and Immunogenetics Department, National Blood Service, Colindale, London, UK CD1d proteins are non-classical MHC class I like molecules presenting lipids, glycolipids and bacterial antigens to T/NKT cells. CD1d-reactive V 24+-NKTcells may contribute to self-tolerance through regional specialisation in a variety of organs and tissues. Previous studies in this laboratory, together with published reports demonstrate that NKT cells are present in cord blood (CB). However, the distribution of CD1d in human APCs has not been fully defined. We have investigated the expression of CD1d on monocytes, monocyte derived DCs (MDDCs) and on myeloid (CD11c+) and lymphoid (CD11c-) DCs from CB and AB using flow cytometry. Equivalent cell populations in adult peripheral blood (AB) were also analysed. Monocytes and DCs were isolated using magnetic columns. MDDCs (n=5) were prepared by culture with GM-CSF and IL-4 for 7 days and matured with TNF-for a further 2 days.
Results: CB monocytes (n=7) expressed higher levels of CD1d than AB (75 ± 9% versus 52 ± 12% respectively). Additionally, 73.6 ± 4.8% of CB CD11c+ DCs (n=5) expressed CD1d whereas only 7.3 ± 6.0% of CB lymphoid DCs were CD1d positive. However, in AB only myeloid DCs expressed CD1d (69.3 ± 6.5%). No significant differences in the percentage of CD1d positive myeloid DCs in CB versus AB were observed. Moreover, the CD1d expression was completely down regulated on CB and AB MDDC. Background: Tolerance induction to alloantigens can be achieved in mouse model using bone marrow donor cells with the objective of obtaining a donor-receptor chimerism. There are different theories about the subtypes cells and the mechanism responsible. Recent data suggest that stromal bone marrow-derived mesenchymal cells (MSC) could participate in this tolerance induction in allogeneic skin transplants.
Poster Group 4 -Cellular
Objective: To define if pig MSC cells modify the alloreactive or xenoreactive response of human lymphocytes.
Results: We obtained, purified and characterized a subpopulation of pig MSC cells (CD18+; CD44+; MHC-DR+; CD56-; CD62-; CD14-) which expanded "in vitro" spontaneously. These cells induced less proliferation of human T lymphocytes than lymph node cells from the same pig, in spite of inducing a higher IL-2 and IFN-γ production. The pig MSC cells were also able to induce TNF-α and IL-10 but not IL-4 or IL-5. IL-2, IFN-γ and TNF-α production was inhibited by the presence of calcineurin inhibitors (Cyclosporine A, Tacrolimus) whereas IL-10 production was not sensitive to these drugs. Pig MSC cells or their supernatants had a inhibitory effect in the "in vitro" clonal expansion induced in a mixed lymphocyte reaction (MLR) both in alloresponse (Human to human model) and in xenoresponse (Pig to human model).
Conclusions: Pig MSC cells, in spite of their low capacity to induce proliferation, induced a high IL-2 production. This discrepancy may be due to inhibitory factors, probably soluble, able to inhibit both alloresponse and xenoresponse. Recently, a population of muscle-derived stem cells (MDSCs) has been identified and characterized in mice as cells with in vitro and in vivo myogenic potential. This study was conducted to characterize the phenotype of MDSCs in humans. We examined muscle biopsies collected from 8 healthy subjects and 8 patients affected from Duchenne Muscular dystrophy. Muscle biopsies were enzimatically dissociated, then cultured on flasks according to the preplating technique. Nonadherent cells (NACs) were collected after 1 hour and characterized by three-colors flow cytometry, to determine the expression of CD34, CD45, CD133, CDw90 (Thy-1), and KDR (VEGF-R2, Vascular Endothelial Grow Factor Receptor). The percentage of cells expressing CD34 did not differ between patients and controls (range 5.6-26.6% and 6-20.5%, respectively). On the other hand, the proportion of CD34+/CD133+ cells was greater in some patients as compared to healthy subjects (range 0.1-3.9% vs 0.1-1.9%). Interestingly, we found that the vast majority (more than 99%) of CD34+ cells lack the expression of both the hematopoietic marker CD45 and KDR but they are Thy-1 positive. Our findings suggest that CD133 is a useful marker for flow-cytometric characterization and sorting of MDCs with ex-vivo myogenic characteristics. The killer immunoglobulin-like receptor (KIR) family of NK receptors is encoded by tandemly arrayed genes on human chromosome 19. 15 loci of KIR genes have been described so far. The gene content in each of the inherited chromosomes varies. Some loci show allelic difference in their coding sequences. Since KIR molecules recognize self-MHC molecules, the combination of the MHC polymorphism and the KIR polymorphism potentially provides vast complexity in individual immune regulation.
HAPLOTYPE DISPLAY ANALYSIS OF THE KIR GENE LOCI
We have used double strand DNA conformation polymorphism (DSCP) and Reference Strand mediated Conformation Analysis (RSCA) in analyses of polymorphism and typing of HLA class I and class II genes. Since the advantages of these methods are applicable to more than two DNA fragments in a single assay, we applied RSCA for analysis of KIR loci. A pair of PCR primers was designed to amplify the genomic fragments including the exon encoding the membrane-proximal conserved immunoglobulin-like domain (D2) from all known KIR sequences. The 13th IHW NK/KIR DNA panel and DNA from 36 Japanese individuals were amplified and subjected to RSCA. Out of the PCR amplicons from 36 Japanese individuals, we were able to identify 19 different gel migration patterns, suggesting 19 loci. The number of peaks in a single lane of the gel is as many as 15. This result demonstrates the power of RSCA in discrimination of highly polymorphic alleles. Correspondent author: Michio Yasunami1
NK AND CD8 T CELLS IMMUNE RECONSTITUTION AND KIR GENE TRANSCRIPTS IN ALLOGENEIC BONE MARROW TRANSPLANTATION
Laure Denis1, Katia Gagne1, Brigitte Gueglio2, Philippe Simon1, Anne Cesbron1, Noel Milpied2, Marc Bonneville3, Gilles Folléa1, Jean-Luc Harrousseau2, Jean-Denis Bignon1 1Blood bank, 2Hematology, 3INSERM U463, Nantes, FRANCE Following allogeneic Bone Marrow Transplantation (BMT), an early recovery of NK and CD8+ lymphocytes has been reported on. Moreover, recent evidence suggests that mismatches at NK-KIR ligands and receptors could play a major role in unrelated BMT. In this study, our objectives focused on the NK and T-CD8 reconstitution during the first 3 months post grafting by evaluating absolute numbers of these cells, their donor or recipient origin and the KIR transcript levels. A total of 13 BMT, including 6 unrelated were selected. NK, CD8+ and CD3+ T cells of peripheral blood were evaluated by flow cytometry at days 14, 30, 60 post-graft. KIR 3DL1 transcriptional rate was first evaluated in real time quantitative PCR over the same period. Following graft, there was a rapid proliferation of NK cells at d14 or d28 to reach a plateau at d60. These NK cells were of donor genotype, and represented a mean range of 32, 40, 46% at d14, 30 and 60 respectively. CD8+ T cells expanded slightly slower until d30. These CD8+ cells represented a mean percentage of 22, 33 and 32 at d14, 30 and 60 respectively but with a great variability according to conditionning regimens (myeloablative or not). These CD8+ T cells could represent up to 58% of the CD3+ T cells (d60). Finally, 3DL1 transcript levels were heterogeneous between recipients but more homogeneous at individual level with a peak correlating with NK peak but preceding it in a majority of patients. To conclude, these results should be confirmed on a larger cohort of patients and extended to activating gene transcript quantitation in KIR mismatched graft combinations exposed to high GvHD rates.
KIR GENE AND HAPLOTYPE FREQUENCIES IN A FRENCH POPULATION
Katia Gagne1, Laure Denis1, Nadine Saintol1, Anne Cesbron1, Gilles Follea1, Jean-Yves Muller2 and Jean-Denis Bignon1. 1Blood Bank, 2 Immunology, CHU Hotel Dieu, Nantes, FRANCE.
Killer cell Ig-like receptors (KIR) encoded by different genes located on chromosome 19 correspond to a family of glycoproteins expressed on NK cells and memory CD8+ T cells. KIR receptors, whose ligands are the HLA class I gene products, exhibit an extensive degree of diversity due to combination of variable gene number and polymorphism. We performed a regional study including 94 healthy Caucasians originated from west part of France to define KIR genotypes, gene and haplotype frequencies according to the main broad groups previously described ("A" and "B"). KIR genotyping was performed by PCR-SSP testing 14 inhibitory and activating KIR genes. The results showed that our western European individuals displayed some genetic features comparatively to other Caucasian populations previously published. Thus, 2DL3 and 2DS3 were statistically increased (93% vs 86% and 37% vs 26% respectively) whereas 2DS1 was decreased (30% vs 45%). In this cohort of 94 individuals, 38 different genotypes were identified and 18 were unique. The most common genotype observed 13 times included only 2DS4/1D as activating KIR genes (haplotype A). Finally, we observed that "A" haplotypes were the most frequent (67%). In summary, in Caucasian population, KIR polymorphism and gene frequencies could also reflect some geographical characteristics as already observed for HLA polymorphism distribution. This should be taken into account particularly in the context of bone marrow transplantation where KIR mismatching between donor and recipient could correlate with a high risk of aGvHD.
DEVELOPMENT OF A MULTIPLEX PCR APPROACH FOR KIR GENOTYPING : ANALYSIS OF KIR REPERTOIRE IN UNRELATED DONOR HEMATOPOIETIC TRANSPLANTS.
Diane Razanajaona, Valérie Dubois, Hamid Assaqa, Anne Thiebaut, Assia Eljaafari, Mauricette Michallet, Lucette Gebuhrer.
HLA laboratory, Hematology Dept, Lyon, France.
Recent studies pointed out the potential role of NK cells alloreactivity in hematopoietic transplantation outcome, through KIR-HLA class I interactions. Subsequently, inclusion of KIR genotyping in donor selection criteria is currently emerging. KIR genotyping was mostly assessed by SSP-PCR detecting the 16 identified KIR genes and pseudogenes.
We developed a multiplex PCR typing using KIR specific primer pairs previously designed by others. Our approach was validated by comparison of multiplex vs monoplex PCR KIR typing of 48 individuals included in the 13th IHWG international workshop. Our approach allowed a faster and less consuming generic KIR typing and is thus more suitable for routine analysis ; we applied the devised method to donor/recipient pairs of unrelated donor hematopoietic cell transplantations.
50 leukemia adult patients were selected for KIR genotype analysis. 4 groups were distinguished according to the presence or absence of HLA-C mismatches, with or without additional mismatches. The first group displayed a single HLA-C mismatch (n=8) ; 2nd and 3rd groups comprised respectively 2 or 3 mismatches including one HLA-C (n=5) or 1 or 2 mismatches at non HLA-C loci (n=5). The 4th group were HLA-matched patients (n=32). KIR/HLA typing were obtained for the first group, the 3 remaining groups being currently under investigation. Results from the 50 pairs will be presented and will hopefully permit to extent the knowledge regarding the influence of NK repertoire in hematopoietic transplantation outcome. Placental abruption is an unpredictable severe complication in pregnancy. In order to investigate the possibility that the activation of the fetal non-adaptive immune system may be involved in the pathogenesis of this disease, IL-6 release from cord blood monocytes was examined by intracellular cytokine staining and flow cytometric analysis. Our results demonstrate that preterm placental abruption (n=15) in contrast to uncontrollable preterm labour (n=33) is associated with significantly (p<0.001) increased release of IL-6 from the fetal monocytes. The same holds true for Rhesus disease that is characterized by a maternal production of antibodies against the rhesus-D antigen expressed by the fetal erythrocytes. This suggests that in the course of Rhesus disease IL-6 release of monocytes is induced by antibody-mediated crosslinking of these cells to the erythrocytes in the fetal circulation. To elucidate this potential mechanism, the presence of anti-HLAantibodies was assessed in the maternal circulation of patients with placental abruption (n=17) and patients with uncontrollable preterm labour (n=29). The percentage of women producing antipaternal HLA-antibodies was significantly (p< 0.01) increased in the group of women with preterm placental abruption (47%) in comparison to women with uncontrollable preterm labour (14%). Our results suggest that an increased humoral immune response of the mother against the fetus is involved in the pathogenesis of placental abruption. The HLA allele frequency distribution of the Mayans from Guatemala has been studied and compared with those of other First American Natives and worldwide populations (a total of 12,364 chromosomes and 6,182 individuals from 60 different populations). The main conclusions are: 1)The closest Amerindian group to Mayans is the Arhuacs, who were the first recorded Caribbean Islands inhabitants. 2)Mayans are not so close to Mesoamerican Zapotec, Mixe and Mixtec Amerindians, who genetically cluster together. Mixe had been related to Mayans only on linguistic bases. 3)DRB1*0407 and DRB1*0802 alleles are found in 50% of Mayans; these alleles are also found in other Amerindians ,but the Mayans high frequencies may be showing a founder effect for this Mesoamerican-Caribbean population. 4)Extended Mayan specific HLA haplotypes are described for the first time. 5)Language and genes do not completely correlate in microgoegraphical studies. 6)Peopling of the Americas was probably more complex than postulated by Greenberg and others (three peopling waves). Significant genetic input from outside is not noticed in Meso and South American Amerindians according to the genetic analyses; while all world populations (including Africans, Europeans, Asians, Australians, Polynesians, North American Na-Dene Indians and Eskimos) are genetically related. Meso and South American Amerindians tend to remain isolated in the neighbour joining, correspondence and plane genetic distances analyses.
Poster Group 7 -Immune
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SNP The polymerase chain reaction (PCR) and the identification of SNPs (single nucleotide polymorphisms) throughout the genome have had a major impact on the study of human population genetics at the DNA level. It is important, however, not to rely on a single set of markers to elucidate the demographic and migrational history of a given population, but to use a range of markers, encompassing the non-recombinant portion of the Y chromosome, the mitochondrial genome and autosomal markers, which may or may not be under selective pressure. PCR has greatly enhanced the ability to type for SNPs. Until recently, however, many detection methods have relied on the use of gels or specially labelled probes. AMDI (Alkaline Mediated Differential Interaction) is a detection system devised in our laboratory which avoids the use of gels, lends itself to automation and high throughput screening, and is simple and inexpensive.
We now describe the typing of a Korean population for a number of markers, including HLA, KIR and SNPs in the non-recombining region of the Y chromosome using AMDI. The results obtained are direct fluorescence readings from a fluorimeter, from which DNA types can be automatically assigned. These results have been compared with those using a gel-based detection system and show good concordance in signal and the presence or absence of a band.
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